News

Stay updated.

OBIO® Celebrates the Advancement of Women in Health Science with WiHI Seed Program and Leadership Awards
01/04/2024

Launched in July 2022 with support from the Government of Canada, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), the OBIO® WiHI aims to bridge the gender disparity in the health science industry, particularly in senior management roles and leadership positions. This year, 11 women-led companies, including Cove Neurosciences lnc., have been selected for the WiHI Seed Program, a key component of the initiative, which addresses the significant barriers that women-led companies face in accessing financing and support.

Read More
The SUDEP Data Alliance Welcomes Cove Neurosciences
06/29/2023

The SUDEP Data Alliance today announced it has welcomed their newest member The partnership aims to develop novel tools to analyze real-world epilepsy data, and advance the Alliance’s mission to understand and prevent Sudden Unexpected Death in Epilepsy (SUDEP).

Read More
Alumni Startup Cove Neurosciences Advances at Hatchery Demo Day 2022
10/05/2022

From brain data software that simplifies neuroscience research to wearable technology that will protect older adults from fall-induced injuries, four University of Toronto startups are moving closer to commercial viability. Among them is Cove Neurosciences Inc., an alumni startup that is bridging the gap between data engineering and neuroscience .

Read More
Ontario Brain Institute announces $700,000 in funding for Canadian neurotech start-ups in inaugural NERVE program
05/12/2022

The Ontario Brain Institute (OBI) is pleased to announce the inaugural NERVE cohort, a group of seven entrepreneurs funded through Canada's single largest award for early-stage neurotechnology development. The seven 2022 NERVE entrepreneurs includes Nardin Samuel of Cove, a company that takes 2D brain data and transforms it into 3D maps that are representative of the brain's complex networks

Read More
Nurosene Announces Strategic Agreement with Brain Analysis Platform, Cove Neurosciences lnc.
05/06/2022

Nurosene Health lnc., a healthtech company focused on delivering innovative AI-based technology solutions for mental performance and wellness, announces that it has entered into a strategic Master Services Agreement with neurotechnology company, Cove Neurosciences Inc.

Read More